# Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged

> **NCT05116618** · — · WITHDRAWN · sponsor: **University of Colorado, Denver**

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** InVisionFirst-Lung ctDNA assay

## Key facts

- **NCT ID:** NCT05116618
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-06
- **Primary completion:** 2022-09-15
- **Final completion:** 2022-09-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cancelled by Sponsor
- **Last updated:** 2022-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05116618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05116618, "Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05116618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*